ClinicalTrials.Veeva

Menu

Optic Disc, Macula, and Retinal Nerve Fiber Layer Measurements Obtained by OCT in Thyroid Associated Ophthalmopathy

N

Neon Hospital

Status

Completed

Conditions

Thyroid Associated Ophthalmopathy

Treatments

Device: Optical Coherence Tomography

Study type

Interventional

Funder types

Other

Identifiers

NCT02766660
2013-379

Details and patient eligibility

About

The aim of the study is to compare the measurements of retinal nerve fiber layer (RNFL), macula and optical disc parameters obtained by optical coherence tomography (OCT), and intraocular pressure (IOP) between the patients with thyroid-associated ophthalmopathy (TAO) and healthy controls.

Full description

One hundred and thirty two eyes of 66 patients with TAO and 72 eyes of 36 healthy controls were included in the study. Proptosis level was determined by Hertel exophthalmometer. Optic disc, peripapillary retinal nerve fiber layer and macula parameters were measured by OCT. All measurements were compared between the patients and age and sex-matched healthy controls.

Enrollment

102 patients

Sex

All

Ages

12 to 73 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Patient group consists the consecutive patients with thyroid associated ophthalmopathy consulted by endocrinology department.

The control group was chosen among healthy volunteers who have

  • no eye pathology,
  • 20/20 vision (corrected or uncorrected),
  • age and sex-matched with the patient group.

Exclusion Criteria:

For both groups, those who had

  • significant sight impairment,
  • high myopia ( < -5Diopters ),
  • high hyperopia ( > +3Diopters ),
  • optic disc anomaly,
  • vitreoretinal interface disease,
  • vascular and degenerative retinal diseases,
  • cornea or lens opacity, ocular surgery history,
  • glaucoma,
  • neurological diseases that can affect the visual field,
  • history of trauma, amblyopia,
  • diplopia,
  • keratitis,
  • history of topical or systemic steroid

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

102 participants in 2 patient groups

Thyroid ophthalmopathy
Other group
Description:
Thyroid associated ophthalmopathy patients were measured by optical coherence tomography.
Treatment:
Device: Optical Coherence Tomography
Control
Other group
Description:
Control group was consisted by age and sex- macthed healthy people adn they were measured by optical coherence tomography.
Treatment:
Device: Optical Coherence Tomography

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems